In light of the correlation between Mo-AMs and IFN-γ+CD8+ T cell accumulation in allografts with BOS, we next set out to analyze the expression of surface molecules on Mo-AMs that control effector CD8+ T cell activation (Figure 8A). This evidence concerns the gene CD8A and Buschke-Ollendorff syndrome.